May 9 |
Regeneron’s gene therapy triumphs twice, restoring hearing in children
|
May 8 |
Regeneron gene therapy improves hearing in child deafness
|
May 8 |
Regeneron gene therapy improves hearing in two children
|
May 8 |
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
|
May 6 |
Regeneron Announces Investor Conference Presentations
|
May 6 |
Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
|
May 5 |
Wall Street Breakfast: The Week Ahead
|
May 4 |
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
|
May 4 |
23 Most Profitable Stocks of the Last 12 Months
|
May 3 |
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
|